Elanco director receives stock unit awards

Elanco Animal Health director Art A. Garcia reported receiving stock-based compensation in the form of common stock units.

Rhea-AI Filing Summary

Elanco Animal Health director Art A. Garcia reported receiving stock-based compensation in the form of common stock units. On May 21, 2026, he acquired 12,196 deferred stock units as a pro-rated annual equity award for non-employee directors and 4,678 restricted stock units as an annual equity award. Both awards were granted at a stated price of $0.00 per share, reflecting compensation rather than open-market purchases. Each line in the filing shows updated direct holdings of Elanco common stock of 108,152 shares and 95,956 shares, respectively, following these grants.

Insider Trade Summary

Grant/Award: 16,874 shares

Grant/Award 2 txns

Insider GARCIA ART A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,678	$0.00	$0.00
Grant/Award	Common Stock	12,196	$0.00	$0.00

Holdings After Transaction: Common Stock — 108,152 shares (Direct)

Footnotes (2)

1. F1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
2. F2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Key Figures

Deferred stock units granted: 12,196 units Restricted stock units granted: 4,678 units Price per share for grants: $0.00 per share +3 more

6 metrics

Deferred stock units granted 12,196 units Grant of deferred stock units as pro-rated annual equity award to non-employee directors on May 21, 2026

Restricted stock units granted 4,678 units Grant of restricted stock units as annual equity award to non-employee directors on May 21, 2026

Price per share for grants $0.00 per share Equity awards granted as compensation, not open-market purchases

Direct holdings after DSU grant 108,152 shares Total Elanco common shares reported following deferred stock unit grant

Direct holdings after RSU grant 95,956 shares Total Elanco common shares reported following restricted stock unit grant

Number of acquire transactions 2 transactions Both coded as A (grant, award, or other acquisition) for non-derivative common stock

Key Terms

deferred stock units, restricted stock units, annual equity award, non-employee members of the Issuer's Board of Directors

4 terms

deferred stock units financial

"Grant of deferred stock units as a pro-rated annual equity award"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

restricted stock units financial

"Grant of restricted stock units as an annual equity award"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual equity award financial

"as an annual equity award to each of the non-employee members"

non-employee members of the Issuer's Board of Directors financial

"to each of the non-employee members of the Issuer's Board of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Art A. Garcia report in his latest Form 4 for ELAN?

Art A. Garcia reported receiving equity compensation in Elanco common stock units. He was granted 12,196 deferred stock units and 4,678 restricted stock units as board-related awards for his role as a non-employee director.

Were Art A. Garcia’s ELAN stock unit awards open-market purchases?

No, the awards were not open-market purchases. Both the 12,196 deferred stock units and 4,678 restricted stock units were granted at $0.00 per share as equity compensation to a non-employee member of Elanco’s Board of Directors.

What types of equity awards did ELAN grant to Art A. Garcia?

Elanco granted Art A. Garcia deferred stock units and restricted stock units. Footnotes describe the 12,196 units as a pro-rated annual deferred stock award and the 4,678 units as an annual restricted stock unit award for non-employee directors.

How many ELAN deferred stock units did Art A. Garcia receive?

He received 12,196 deferred stock units in Elanco common stock. The filing notes this grant as a pro-rated annual equity award provided to each non-employee member of the company’s Board of Directors.

How many ELAN restricted stock units did Art A. Garcia receive?

He received 4,678 restricted stock units in Elanco common stock. According to the filing, this grant represents an annual equity award to each non-employee member serving on Elanco’s Board of Directors.

What are the updated direct ELAN share holdings reported after these grants?

The Form 4 shows direct holdings of 108,152 Elanco common shares after the deferred stock unit grant and 95,956 shares after the restricted stock unit grant, reflecting updated positions associated with each separate stock-based award entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARCIA ART A

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		4,678(1)	A	$0	95,956	D
Common Stock	05/21/2026		A		12,196(2)	A	$0	108,152	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

2. Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Art A. Garcia	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)